Molecular mechanisms of the conjugated α,β-unsaturated carbonyl derivatives:: Relevance to neurotoxicity and neurodegenerative diseases

被引:138
|
作者
LoPachin, Richard M. [1 ]
Barber, David S. [2 ]
Gavin, Terrence [3 ]
机构
[1] Montefiore Med Ctr, Dept Anesthesiol, Albert Einstein Coll Med, Bronx, NY 10467 USA
[2] Univ Florida, Ctr Environm & Human Toxicol, Gainesville, FL 32611 USA
[3] Iona Coll, Dept Chem, New Rochelle, NY USA
关键词
acrylamide; acrolein; Alzheimer's disease; 4-hydroxy-2-nonenal; synaptotoxicity; neurodegeneration;
D O I
10.1093/toxsci/kfm301
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Conjugated alpha,beta-unsaturated carbonyl derivatives such acrylamide, acrolein, and 4-hydroxy-2-nonenal (HNE) are members of a large class of chemicals known as the type-2 alkenes. Human exposure through diet, occupation, and pollution is pervasive and has been linked to toxicity in most major organs. Evidence suggests that these soft electrophiles produce toxicity by a common mechanism involving the formation of Michael-type adducts with nucleophilic sulfhydryl groups. In this commentary, the adduct chemistry of the alpha,beta-unsaturated carbonyls and possible protein targets will be reviewed. We also consider how differences in electrophilic reactivity among the type-2 alkenes impact corresponding toxicokinetics and toxicological expression. Whereas these concepts have mechanistic implications for the general toxicity of type-2 alkenes, this commentary will focus on the ability of these chemicals to produce presynaptic damage via protein adduct formation. Given the ubiquitous environmental presence of the conjugated alkenes, discussions of molecular mechanisms and possible neurotoxicological risks could be important. Understanding the neurotoxicodynamic of the type-2 alkenes might also provide mechanistic insight into neurodegenerative conditions where neuronal oxidative stress and presynaptic dysfunction are presumed initiating events. This is particularly germane to a recent proposal that lipid peroxidation and the subsequent liberation of acrolein and HNE in oxidatively stressed neurons mediate synaptotoxicity in brains of Alzheimer's disease patients. This endogenous neuropathogenic process could be accelerated by environmental type-2 alkene exposure because common nerve terminal proteins are targeted by alpha,beta-unsaturated carbonyl derivatives. Thus, the protein adduct chemistry of the conjugated type-2 alkenes offers a mechanistic explanation for the environmental toxicity induced by these chemicals and might provide insight into the pathogenesis of certain human neurodegenerative diseases.
引用
收藏
页码:235 / 249
页数:15
相关论文
共 50 条
  • [21] Nanomaterials for neurodegenerative diseases: Molecular mechanisms guided design and applications
    Li, Tianzhong
    Hou, Xueyan
    Qi, Yu
    Duan, Xiaohan
    Yan, Pengcheng
    Zhu, Haoru
    Xie, Zhongjian
    Zhang, Han
    NANO RESEARCH, 2022, 15 (04) : 3299 - 3322
  • [22] Intermittent fasting and neurodegenerative diseases: Molecular mechanisms and therapeutic potential
    Lv, Renjun
    Liu, Bin
    Jiang, Ziying
    Zhou, Runfa
    Liu, Xiaoxing
    Lu, Tangsheng
    Bao, Yanping
    Huang, Chunxia
    Zou, Guichang
    Zhang, Zongyong
    Lu, Lin
    Yin, Qingqing
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2025, 164
  • [23] Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets
    Lijun Dai
    Li Zou
    Lanxia Meng
    Guifen Qiang
    Mingmin Yan
    Zhentao Zhang
    Molecular Neurobiology, 2021, 58 : 2183 - 2201
  • [24] Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets
    Dai, Lijun
    Zou, Li
    Meng, Lanxia
    Qiang, Guifen
    Yan, Mingmin
    Zhang, Zhentao
    MOLECULAR NEUROBIOLOGY, 2021, 58 (05) : 2183 - 2201
  • [25] Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review
    Irish, Bryan
    Khan, Zafar
    Jain, Pooja
    Nonnemacher, Michael
    Pirrone, Vanessa
    Rahman, Saifur
    Rajagopalan, Nirmala
    Suchitra, Joyce
    Mostoller, Kate
    Wigdahl, Brian
    AMERICAN JOURNAL OF INFECTIOUS DISEASES, 2009, 5 (03) : 231 - 258
  • [26] Molecular Mechanisms in the Design of Novel Targeted Therapies for Neurodegenerative Diseases
    Nowak, Ilona
    Pazdzior, Marlena
    Sarna, Robert
    Madej, Marcel
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (06) : 5436 - 5453
  • [27] Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms
    Haddadi, Rasool
    Shahidi, Zahra
    Eyvari-Brooshghalan, Shahla
    PHYTOMEDICINE, 2020, 79
  • [28] Nanomaterials for neurodegenerative diseases: Molecular mechanisms guided design and applications
    Tianzhong Li
    Xueyan Hou
    Yu Qi
    Xiaohan Duan
    Pengcheng Yan
    Haoru Zhu
    Zhongjian Xie
    Han Zhang
    Nano Research, 2022, 15 : 3299 - 3322
  • [29] Dissecting the Molecular Mechanisms of Neurodegenerative Diseases through Network Biology
    Santiago, Jose A.
    Bottero, Virginie
    Potashkin, Judith A.
    FRONTIERS IN AGING NEUROSCIENCE, 2017, 9
  • [30] RNA processing-associated molecular mechanisms of neurodegenerative diseases
    Tang, Anna Y.
    JOURNAL OF APPLIED GENETICS, 2016, 57 (03) : 323 - 333